Loading clinical trials...
Loading clinical trials...
The primary aim of the study is to assess the genotype - phenotype correlations of the CNS manifestations of late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal, rare, recessive disorder of...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Weill Medical College of Cornell University
Collaborators
NCT03307304 · Juvenile Neuronal Ceroid Lipofuscinosis (CLN3), Batten Disease
NCT03333200 · MLD, Krabbe Disease, and more
NCT01873924 · Neuronal Ceroid Lipofuscinosis, Neuronal Ceroid Lipofuscinosis CLN1, and more
NCT02254863 · Adrenoleukodystrophy, Batten Disease, and more
NCT04273243 · CLN6, Batten Disease
Weill Cornell Medicine
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions